BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 29096618)

  • 1. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Tai AS; Sherrard LJ; Kidd TJ; Ramsay KA; Buckley C; Syrmis M; Grimwood K; Bell SC; Whiley DM
    BMC Pulm Med; 2017 Nov; 17(1):138. PubMed ID: 29096618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
    Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
    Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre.
    Wee BA; Tai AS; Sherrard LJ; Ben Zakour NL; Hanks KR; Kidd TJ; Ramsay KA; Lamont I; Whiley DM; Bell SC; Beatson SA
    BMC Genomics; 2018 Aug; 19(1):644. PubMed ID: 30165811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres.
    Smith DJ; Ramsay KA; Yerkovich ST; Reid DW; Wainwright CE; Grimwood K; Bell SC; Kidd TJ
    Respirology; 2016 Feb; 21(2):329-37. PubMed ID: 26711802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis.
    Tai AS; Bell SC; Kidd TJ; Trembizki E; Buckley C; Ramsay KA; David M; Wainwright CE; Grimwood K; Whiley DM
    PLoS One; 2015; 10(12):e0144022. PubMed ID: 26633539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres.
    Kidd TJ; Ramsay KA; Hu H; Marks GB; Wainwright CE; Bye PT; Elkins MR; Robinson PJ; Rose BR; Wilson JW; Grimwood K; Bell SC;
    Eur Respir J; 2013 May; 41(5):1091-100. PubMed ID: 22878877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levofloxacin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection among patients with cystic fibrosis.
    Stockmann C; Hillyard B; Ampofo K; Spigarelli MG; Sherwin CM
    Expert Rev Respir Med; 2015 Feb; 9(1):13-22. PubMed ID: 25417708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
    Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD
    BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis.
    Amin R; Lam M; Dupuis A; Ratjen F
    Pediatr Pulmonol; 2011 Jun; 46(6):554-8. PubMed ID: 21337727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
    Al-Aloul M; Nazareth D; Walshaw M
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):299-305. PubMed ID: 24219814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium.
    Collie D; Glendinning L; Govan J; Wright S; Thornton E; Tennant P; Doherty C; McLachlan G
    PLoS One; 2015; 10(11):e0142097. PubMed ID: 26544950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platform.
    Syrmis MW; Moser RJ; Kidd TJ; Hunt P; Ramsay KA; Bell SC; Wainwright CE; Grimwood K; Nissen MD; Sloots TP; Whiley DM
    J Med Microbiol; 2013 May; 62(Pt 5):734-740. PubMed ID: 23412772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
    Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
    Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.
    Sherrard LJ; Tai AS; Wee BA; Ramsay KA; Kidd TJ; Ben Zakour NL; Whiley DM; Beatson SA; Bell SC
    PLoS One; 2017; 12(3):e0172179. PubMed ID: 28273168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations.
    Chin M; De Zoysa M; Slinger R; Gaudet E; Vandemheen KL; Chan F; Hyde L; Mah TF; Ferris W; Mallick R; Aaron SD
    J Cyst Fibros; 2015 Jul; 14(4):482-9. PubMed ID: 25544473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
    Hansen CR; Pressler T; Koch C; Høiby N
    J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.
    Mowat E; Paterson S; Fothergill JL; Wright EA; Ledson MJ; Walshaw MJ; Brockhurst MA; Winstanley C
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1674-9. PubMed ID: 21297072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
    Greenwood J; Schwarz C; Sommerwerck U; Nash EF; Tamm M; Cao W; Mastoridis P; Debonnett L; Hamed K
    Ther Adv Respir Dis; 2017 Jul; 11(7):249-260. PubMed ID: 28614995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.